PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26714035-10	2015	Active reduction of alpha-sma was observed in hHSC and the liver sections of losartan-HA micelle-treated mice.	Losartan	77-85	actin alpha 2, smooth muscle, aorta	Mus musculus	20-29	
27983984-3	2016	Moreover, the expression of alpha-SMA and Myh11 induced by Ang II was blocked by pretreatment of EpiCs with the AT1 receptor antagonist losartan, but not the AT2 receptor antagonist PD123319.	Losartan	136-144	actin alpha 2, smooth muscle, aorta	Mus musculus	28-37	
32927089-7	2020	The reduction of hepatic stellate cell activation after treatment with ChiBil-losartan was analyzed based on the expression of alpha-smooth muscle actin (alpha-SMA) in both in vitro and in vivo studies.	Losartan	78-86	actin alpha 2, smooth muscle, aorta	Mus musculus	154-163	
29890165-8	2018	The hepatic areas stained with Sirius red and thenumber of cells marked by alpha-SMA in animals treated with aliskiren, bradykinin, lisinopril and losartan were diminished when compared to control group, demonstrating reduced hepatic fibrosis after RAS blockade.	Losartan	147-155	actin alpha 2, smooth muscle, aorta	Mus musculus	75-84	
28461455-3	2017	METHODS AND RESULTS: Acta2-/- mice have an increased number of elastic lamellae in the ascending aorta and progressive aortic root dilation as assessed by echocardiography that can be attenuated by treatment with losartan, an angiotensin II (AngII) type 1 receptor blocker.	Losartan	213-221	actin alpha 2, smooth muscle, aorta	Mus musculus	21-26